Tower Research Capital LLC (Trc) Repligen Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Repligen Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,551 shares of RGEN stock, worth $567,698. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,551

Previous 3,984 10.87%

Holding current value

$567,698

Previous $502,000 5.18%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $51,869 - $72,462	-433 Reduced 10.87%	3,551 $528,000
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $169,920 - $259,057	1,416 Added 55.14%	3,984 $502,000
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $566,135 - $690,912	-3,315 Reduced 56.35%	2,568 $472,000
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $419,574 - $681,161	-3,675 Reduced 38.45%	5,883 $1.06 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $266,873 - $339,428	1,923 Added 25.19%	9,558 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $450,557 - $586,909	3,255 Added 74.32%	7,635 $1.08 Million
Q1 2023 May 09, 2023	BUY	$154.26 - $198.1 $302,195 - $388,077	1,959 Added 80.92%	4,380 $737,000
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $99,238 - $134,762	611 Added 33.76%	2,421 $410,000
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $661,892 - $1.06 Million	-4,126 Reduced 69.51%	1,810 $339,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $81,735 - $109,239	581 Added 10.85%	5,936 $964,000
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $104,451 - $167,158	648 Added 13.77%	5,355 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $493,199 - $606,504	1,992 Added 73.37%	4,707 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $435,116 - $724,285	-2,234 Reduced 45.14%	2,715 $785,000
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $210,654 - $280,606	1,270 Added 34.52%	4,949 $988,000
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $2.61 Million - $3.27 Million	-14,470 Reduced 79.73%	3,679 $715,000
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $38,204 - $53,295	-258 Reduced 1.4%	18,149 $3.48 Million
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $357,484 - $461,831	-2,918 Reduced 13.68%	18,407 $2.72 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $2 Million - $2.97 Million	21,168 Added 13482.8%	21,325 $2.64 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $209,426 - $269,030	-2,465 Reduced 94.01%	157 $15,000
Q4 2019 Feb 07, 2020	BUY	$73.84 - $93.08 $66,899 - $84,330	906 Added 52.8%	2,622 $243,000
Q3 2019 Nov 05, 2019	BUY	$76.65 - $95.51 $111,065 - $138,393	1,449 Added 542.7%	1,716 $131,000
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $1,517 - $2,406	28 Added 11.72%	267 $23,000
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $11,818 - $15,009	239 New	239 $14,000
Q4 2017 Feb 09, 2018	SELL	$32.53 - $38.92 $74,688 - $89,360	-2,296 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $84,906 - $105,753	2,296	2,296 $88,000

Others Institutions Holding RGEN

# of Institutions

476

Shares Held

54.5M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.87B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Repligen Corp Transaction History